clostridium%20difficile%20infection
CLOSTRIDIUM DIFFICILE INFECTION
Clostridium difficile infection is commonly associated with antibiotic treatment and is one of the most common nosocomial infections.
Symptoms usually start on days 4-9 of antibiotic treatment, but may also occur up to 8-10 weeks after discontinuation of antibiotics.
Discontinuation of antibiotics may be the only measure needed for patients with only mild diarrhea, no fever, no abdominal pain nor a high WBC count.
Cessation of antibiotics allows for reconstitution of the normal colonic microflora and markedly reduces risk of relapse.

Introduction

  • C difficile infection is commonly associated w/ antibiotic treatment & is one of the most common nosocomial infections

Signs and Symptoms

  • Symptoms usually start on days 4-9 of antibiotic treatment, but may also occur up to 8-10 weeks after discontinuation of antibiotics

Mild Disease

  • Watery diarrhea which is rarely bloody
  • Cramping abdominal pain, tenesmus
  • Anorexia, malaise
  • Slightly increased white blood cell (WBC) count

Moderate Disease

  • Fever
  • Dehydration
  • Nausea & vomiting
  • Abdominal tenderness
  • Leukemoid reaction

Severe Disease

  • Sepsis or shock
  • Acute abdomen which may be due to colonic perforation
  • Toxic megacolon, ascites, paralytic ileus
  • Hypoalbuminemia, increased WBC count & serum creatinine & lactate levels
  • Diarrhea may be of lesser severity in severe disease

Risk Factors

  • Antibiotic therapy
    • Antibiotics most commonly implicated are the cephalosporins, aminopenicillins & Clindamycin
    • Macrolides & other penicillins are less commonly involved
    • Prolonged antibiotic administration increases the risk of C difficile colitis, but even a brief exposure to a single antibiotic may cause disease
  • Intensive care unit (ICU) admission
  • Advanced age
  • Severe comorbid illnesses
  • Immunosuppressive therapy
  • Recent surgery
  • Use of a nasogastric tube
  • Use of antacids
  • Prolonged stay in the hospital
  • Residing in a nursing home
  • Sharing a hospital room w/ a C difficile-infected patient
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 14 Aug 2018
A new study reinforces the gut-brain connection in Alzheimer’s disease (AD), untangling the complex interplay between gut and brain health that could potentially lead to new therapies targeted at manipulating the gut microbiome to treat AD.
Roshini Claire Anthony, 6 days ago

Reducing the dose of regorafenib did little to affect the overall tolerability of the drug in patients with metastatic colorectal cancer (mCRC), according to the phase II REARRANGE* trial presented at ESMO GI 2019.